ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Contents lists available at ScienceDirect 
ArtiÔ¨Åcial Intelligence in the Life Sciences 
journal homepage: www.elsevier.com/locate/ailsci 
Research Article 
Interpretation of multi-task clearance models from molecular images 
supported by experimental design 
Andr√©s Mart√≠nez Mora a , Mickael Mogemark a , Vigneshwari Subramanian a , Filip Miljkovi ƒá b , ‚àó 
a Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden 
b Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden 
a r t i c l e 
i n f o 
Keywords: 
Metabolic stability 
Convolutional neural networks 
Model interpretability 
Deep learning 
Pharmacokinetics 
a b s t r a c t 
Recent methodological advances in deep learning (DL) architectures have not only improved the performance 
of predictive models but also enhanced their interpretability potential, thus considerably increasing their trans- 
parency. In the context of medicinal chemistry, the potential to not only accurately predict molecular properties, 
but also chemically interpret them, would be strongly preferred. Previously, we developed accurate multi-task 
convolutional neural network (CNN) and graph convolutional neural network (GCNN) models to predict a set of 
diverse intrinsic metabolic clearance parameters from image- and graph-based molecular representations, respec- 
tively. Herein, we introduce several model interpretability frameworks to answer whether the model explanations 
obtained from CNN and GCNN multi-task clearance models could be applied to predict chemical transforma- 
tions associated with experimentally conÔ¨Årmed metabolic products. We show a strong correlation between the 
CNN pixel intensities and corresponding clearance predictions, as well as their robustness to diÔ¨Äerent molecular 
orientations. Using actual case examples, we demonstrate that both CNN and GCNN interpretations frequently 
complement each other, suggesting their high potential for combined use in guiding medicinal chemistry design. 
Introduction 
Machine learning (ML), as a part of a much larger artiÔ¨Åcial intel- 
ligence (AI) methodological spectrum, continues to gain considerable 
attention across a myriad of medicinal chemistry and drug discovery ap- 
plications [1‚Äì4] . These methods are commonly employed to derive sta- 
tistical quantitative-structure property relationship (QSPR) models for 
a range of diÔ¨Äerent molecular properties, such as bioactivity [5] , ani- 
mal [6] and human [7] pharmacokinetics, and toxicity [8] . Typically, 
such models learn to associate structural patterns of available chemi- 
cal structure, often encoded as predeÔ¨Åned molecular features (descrip- 
tors) or graph-based embeddings, with a molecular property of interest 
obtained through established experimental procedures [9] . If properly 
validated, these models could potentially extrapolate learned molecu- 
lar features with great accuracy and enable prospective application to 
new chemical series, which plays a major role in the progression of 
novel candidate molecules. In this respect, chemical transformations 
predicted to condition desirable molecular properties could be priori- 
tized early on, hence shortening the length of design-make-test-analyze 
cycle. 
In addition, the potential to not only accurately predict molecular 
endpoints, but also chemically interpret them, would be strongly pre- 
‚àó Corresponding author: Pepparedsleden 1, SE-43183 Gothenburg, Sweden. Phone: + 46-73-699-3320. 
E-mail address: Ô¨Ålip.miljkovic@astrazeneca.com (F. Miljkovi ƒá) . 
ferred in medicinal chemistry practice. Clearly, model interpretability 
has gathered much interest in recent years as a methodological frame- 
work which aims to identify chemical modiÔ¨Åcations that correlate with 
dependent variables, resulting in observed experimental measurements 
[10‚Äì15] . Model explanations, eÔ¨Äectively combined with expert knowl- 
edge, have the potential to guide rational drug design more conve- 
niently, hence encouraging medicinal chemistry practitioners to read- 
ily apply in silico approaches. Thus, model-assisted hypothesis gener- 
ation through the application of integrated or add-on interpretability 
architectures could further propagate the acceptance of computational 
methods in pharmaceutical sciences. Contrary to acquired attention, in- 
terpretable ML has only been very little practically explored, as most 
of the model development focuses on improving performance accuracy, 
yet with only a marginal success. For a more detailed discussion on ex- 
plainable ML models for property prediction, readers are referred to a 
recent perspective article [16] . 
Deep learning (DL), as a methodological component of ML, has made 
signiÔ¨Åcant progress in biological and medical sciences, particularly for 
image analysis where convolutional neural networks (CNNs) have fun- 
damentally been applied [ 17 , 18 ]. Unsurprisingly, attempts have been 
made to repurpose pre-established CNN frameworks for the prediction 
of diÔ¨Äerent compound properties based on molecular images [19‚Äì23] . 
https://doi.org/10.1016/j.ailsci.2022.100048 
Received 27 September 2022; Received in revised form 7 November 2022; Accepted 1 December 2022 
Available online 2 December 2022 
2667-3185/¬© 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
In this regard, molecular images are utilized for representation learn- 
ing to correlate implicit chemical information encoded in pixels with 
a learned experimental endpoint. Highly predictive models with on par 
accuracy to state-of-the-art structural representations were acquired, in- 
dicating that molecular image-based models have the potential to be ap- 
plied across a variety of molecular property prediction tasks. However, 
notable performance advantage over simpler structure-based ML mod- 
els is yet to be attained. A potential advantage of CNN models is in the 
abundance of interpretability methods that have become increasingly 
available recently, particularly for medical image analysis [24] . In med- 
ical imaging, it soon became evident that without model explanations 
there would be very little value in applying CNN methodology solely for 
predicting label outputs [24] . Therefore, eÔ¨Äorts have been made to ac- 
commodate existing and introduce novel interpretability approaches for 
medical image applications, thus increasing practicality and conÔ¨Ådence 
in utilizing CNN models [24] . Much like clinical practitioners, medicinal 
chemists too require model interpretations to aid the decision-making 
process, but also to expose hidden data trends that would otherwise re- 
main unnoticed. 
Whereas the use of interpretability approaches in medical imaging 
has a longstanding tradition (readers are referred to a recent review ar- 
ticle [24] ), the application on molecular images has only recently been 
considered. For example, Zhong et al. developed CNN models to predict 
compound rate constants towards OH radicals, which were then inter- 
preted using gradient-weighted class activation mappings [25] . These 
interpretations correctly indicated structural features responsible for 
molecular reactivity [25] . In another work, Iqbal et al. studied molecular 
images to distinguish between close structural analogs forming activity 
cliÔ¨Äs (ACs) and those that did not [21] . Besides establishing that molec- 
ular images could be applied to predict ACs with high accuracy, the 
mapping of gradient weights from convolutional layers identiÔ¨Åed char- 
acteristic structural features that contributed to these predictions [21] . 
In the extension of this work, the authors learned frequently occurring 
functional groups from the images of AC/non-AC pairs to build transfer 
learning models with aim to improve the accuracy and interpretability 
of CNN models [26] . They demonstrated that the retraining of functional 
group prediction models optimized weights of the convolutional layer 
and further enhanced the prediction accuracy. In addition, they used 
visualizations to discuss the rationale for the performance improvement 
based on the ability of CNN models to learn functional group chemistry 
[26] . 
Previously, we systematically explored the application of multi-task 
CNN models to predict diÔ¨Äerent in vitro clearance endpoints from molec- 
ular image representations [23] . We conÔ¨Årmed that CNNs were suc- 
cessful at capturing implicit chemical relationships contained in images 
using several increasingly challenging data splitting strategies. More- 
over, model benchmarking with conventional ML and DNN methods 
trained with structure-based representations, as well as graph convolu- 
tional neural networks (GCNN), revealed on par or increased accuracy 
of CNNs with clear beneÔ¨Åt of multi-task learning. Our Ô¨Åndings indicated 
that CNN models built from molecular images could successfully be used 
to learn multiple clearance parameters [23] . Herein, we extend our re- 
search question to answer whether CNN models built from molecular im- 
ages, as well as methodologically similar GCNN models, could be used to 
explain chemical modiÔ¨Åcations associated with the intrinsic metabolic 
reactions. Understanding mechanisms of drug metabolic transforma- 
tions has wide implications on the development of small molecule ther- 
apeutics including, but not limited to, drug activity in vivo (pharmaco- 
dynamics), distribution and elimination processes (pharmacokinetics), 
as well as safety liabilities which could be attributed to dosing (poten- 
tial accumulation eÔ¨Äects), oÔ¨Ä-target pharmacology, or chemical reactiv- 
ity. We illustrate the potential of our interpretability models in practice 
where we attempt to reconcile the model-derived interpretations with 
the experimentally conÔ¨Årmed products of metabolism obtained through 
the respective clearance assays. Our Ô¨Åndings are presented in the fol- 
lowing. 
Methods and materials 
Intrinsic clearance data 
Detailed information regarding intrinsic clearance data used for CNN 
and GCNN model building, evaluation, and interpretability exploration 
is described elsewhere [23] . In brief, experimental data for human hep- 
atocyte intrinsic clearance (HH CLint), human liver microsome intrinsic 
clearance (HLM CLint), rat hepatocyte intrinsic clearance (RH CLint), 
and dog hepatocyte intrinsic clearance (DH CLint) were extracted and 
curated from AstraZeneca internal sources. In total, 139,907 unique 
compounds were identiÔ¨Åed for model building and evaluation, with a 
varying number of available data points for diÔ¨Äerent clearance parame- 
ters. For example, HLM CLint and RH CLint measurements, as most com- 
monly measured clearance parameters upon compound synthesis, were 
available for 101,913 and 79,043 compounds, respectively, whereas HH 
CLint and DH CLint (which are evaluated comparatively later) were only 
available for 21,616 and 6747 compounds, respectively. For the pur- 
pose of model evaluation and interpretability, same random stratiÔ¨Åed 
80/20 training-test set splits were used for both CNN and GCNN models 
[23] . 
Convolutional neural network models 
Previously, we systematically explored the application of multi-task 
CNN models to accurately predict four commonly investigated intrinsic 
metabolic clearance parameters from molecular image representations 
[23] . CNNs comprise a number of convolutional blocks which extract 
features from adjacent image pixels, followed by the non-linear map- 
pings and pooling operators that learn these features at diÔ¨Äerent scales: 
in the context of molecular image recognition, shallow layers focus on 
atom-wise features whereas deeper layers on global structural patterns. 
Extracted features are then processed by a fully-connected block which 
combines matrix multiplications and non-linear mappings to provide 
Ô¨Ånal prediction values. DiÔ¨Äerent CNN architectures, hyperparameter 
combinations, and image representations were explored to build Ô¨Ånal 
predictive models. We subjected the training set (80% of the total 
data) to three-fold cross-validation with the aim of selecting an optimal 
hyperparameter set. Early stopping with a patience of 15 epochs (of a 
maximum of 150) was applied during the cross-validation (two folds 
were used to train the models and the remaining fold to validate them) 
to alleviate potential overÔ¨Åtting. CoeÔ¨Écient of determination (R 2 ) and 
root-mean-square error (RMSE) were used to assess model performance, 
the latter being also applied during the cross-validation stage. Best 
performing CNN models contained ResNet [27] 152 architecture, two 
fully connected layers with a dropout rate of 0.50, batch size of 128, 
learning rate of 2 √ó 10 ‚àí 4 , Adam optimizer, batch normalization, and 
were optimized using Huber loss [28] . Additionally, we investigated 
several molecular image representations and selected 240 √ó 240 pixel 
embeddings of two-dimensional molecular structure, with a Ô¨Åxed 
resolution of 0.03 √Ö/pixel and color-coded rendition of heavy atoms 
(e.g., red for oxygen, blue for nitrogen, etc.) as the Ô¨Ånal model input. 
These models showed on par or increased accuracy compared to the 
state-of-the-art machine learning methods trained on structure- and 
graph-based Ô¨Ångerprints, with a reasonably good performance on the 
random test set: HH CLint (R 2 = 0.57 ¬± 0.003, RMSE = 0.32 ¬± 0.001), 
HLM CLint (R 2 = 0.57 ¬± 0.001, RMSE = 0.31 ¬± 0.001), 
RH CLint (R 2 = 0.58 ¬± 0.001, RMSE = 0.36 ¬± 0.001), 
and DH CLint (R 2 = 0.52 ¬± 0.005, RMSE = 0.36 ¬± 0.002) 
[23] . 
Graph convolutional neural network models 
Together with CNNs, we also reported the performance of multi-task 
clearance models using GCNNs [23] . Here, the directed message-passing 
neural network framework named Chemprop [29] was applied, which 
2 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
combines feature extraction from molecular graph representations 
(atoms encoded as nodes and bonds as edges) and prediction potential 
in an end-to-end manner [29] . As a method conceptually close to CNNs, 
GCNNs displayed comparable performance in a multi-task setting. Opti- 
mal GCNN model conÔ¨Åguration had four message-passing layers, GCNN 
layer size of 900, two feedforward layers with a dropout rate of 0.15, 
and RMSE as a loss function. For the same random test set, the GCNN 
models showed performance that was comparable to CNNs: HH CLint 
(R 2 = 0.57 ¬± 0.02, RMSE = 0.31 ¬± 0.01), HLM CLint (R 2 = 0.53 ¬± 0.03, 
RMSE = 0.33 ¬± 0.01), RH CLint (R 2 = 0.58 ¬± 0.02, RMSE = 0.36 ¬± 0.01), 
and DH CLint (R 2 = 0.48 ¬± 0.02, RMSE = 0.37 ¬± 0.01) [23] . This fur- 
ther qualiÔ¨Åed CNN and GCNN clearance models for their comparative 
interpretability assessment. 
Interpretation of image-based models 
We investigated several existing interpretability frameworks com- 
monly applied in CNN tasks: 
‚Ä¢ Class activation maps (CAMs): Interpretations are supplied by prop- 
agating learned model gradients from each predicted clearance end- 
point to the last layer of the convolutional backbone, resulting in 
a compressed low-dimensional representation of the interaction be- 
tween learned gradients and an evaluated image [30] . The learned 
gradients can be conceived as the contributions of each image el- 
ement to the Ô¨Ånal model prediction. Since the representation from 
the last layer of the convolutional backbone is low-dimensional, it 
is required to be upsampled to its original size by an interpolation 
algorithm. This yields coarse-colored patches that are then projected 
atop the corresponding structural features of the query image, which 
in turn supply the information describing increased or decreased 
clearance contributions. CAMs were implemented using PyTorch 
[31] . 
‚Ä¢ Shapley additive explanations (SHAP): A model-agnostic method 
that uses approximation of Shapley values for the interpretation of 
diÔ¨Äerent image pixels. Originating from the game theory, SHAP ap- 
proximates the contribution [32] of each image pixel to the Ô¨Ånal 
prediction value derived by the CNN model. These values are then 
approximated as the weights of a local linear model built by the per- 
turbation of query images, which are subsequently Ô¨Åt to the CNN 
outputs [33] . SHAP approach was implemented using Captum li- 
brary [34] . 
‚Ä¢ Integrated gradients (IGs): The method compares the gradients that 
are learned by the model trained on baseline images (e.g., images 
consisting of ‚Äòzero‚Äô pixels, images containing white noise, etc.) to 
those derived from the query images. The assessment is performed 
gradually by generating interpolations between the baseline and the 
query images, which allows for an in-depth evaluation of the gradi- 
ents contributing the most to the predictions [35] . Gradients display- 
ing the greatest variation are considered to supply the most relevant 
information concerning analyzed image pixels. As IGs explore im- 
age contributions at a pixel level, they provide similar resolution of 
detail for the obtained explanations (i.e., each pixel is individually 
interpreted). Similar to SHAP, IG approach introduces a degree of 
randomness to the resulting interpretations (even with a Ô¨Åxed ran- 
dom seed), although to a lesser extent than SHAP. To increase the 
robustness, the method was run four times and the outputs were av- 
eraged to derive Ô¨Ånal interpretations. IG method was applied using 
Captum library [34] . 
‚Ä¢ Occlusion: An ablation method which substitutes patches of query 
images with noisy patches, thus evaluating the changes in the model 
output. Pixels showing the largest diÔ¨Äerences in the model output 
are the ones interpreted to contribute the most to the predictions 
[36] . The generated patches were 15 √ó 15 pixels in size, with a win- 
dow displacement of 8 √ó 8 pixels, which yielded blurry non-local 
interpretations. Captum library was used to implement the method 
[34] . 
From the methods investigated, only CAMs and IGs were proceeded 
to the interpretability discussion. The other two methods (SHAP and Oc- 
clusion) were discarded for diÔ¨Äerent reasons: SHAP output was highly 
inÔ¨Çuenced by the randomness of the perturbed images (four prediction 
repeats were notably diÔ¨Äerent to average the Ô¨Ånal output) and the Oc- 
clusion method performed signiÔ¨Åcantly slower compared to others, mak- 
ing its application the least practical. 
The global assessment of CNN interpretation methods was performed 
by mathematically evaluating the relationship between the CAM/IG in- 
terpretations and the prediction values obtained by the model. For each 
predicted compound, mean pixel intensity (given as an average of image 
pixel values) of the interpretation layer (for the interpretability purposes 
superimposed on the molecular image) derived by the two methods were 
extracted for each clearance endpoint. For both CAM and IG methods, 
mean pixel intensities were normalized in a value range between 0 and 
1. As IGs only provide interpretations for the pixels constituting molecu- 
lar structure, only these pixels were considered for the evaluation. Pear- 
son correlation coeÔ¨Écients between mean pixel intensities and predic- 
tion values were calculated to determine interpretation method sensi- 
tivity to the actual CNN predictions. Furthermore, we brieÔ¨Çy discussed 
the impact of data augmentation (i.e., diÔ¨Äerent rotations of molecular 
structure) on the robustness of CNN model predictions and interpreta- 
tions. 
Interpretation of graph-based models 
Chemprop GCNN framework [29] contains a built-in interpretability 
module which relies on the Monte Carlo Tree Search (MCTS) algorithm. 
For each compound, MCTS algorithm iteratively evaluates the contri- 
bution of all possible molecular substructures to the Ô¨Ånal prediction, 
following a random order [37] . A maximum substructure size is deÔ¨Åned 
as one of the hyperparameters to alleviate computational costs. Thus, 
the sampled substructural motif that best fulÔ¨Ålls the size requirement is 
selected as the most relevant one. All graph nodes and edges analyzed 
for a particular substructure are adjacent to each other, which limits the 
output to a single continuous substructural pattern. This is a major dif- 
ference in comparison to image-based approaches, which also poses a 
limitation given that metabolic transformation could take place at mul- 
tiple, often disconnected, substructural positions. Unlike CAMs and IGs, 
MCTS does not provide information regarding the level of contribution 
for each highlighted molecular fragment. Pseudocode for both CNN and 
GCNN methods is included in Fig. S1 of the Supplementary methods. 
Experimentally proposed metabolic products 
Liver microsomes and hepatocytes can be applied to investigate po- 
tential oxidative (microsomes and hepatocytes) and conjugative (only 
hepatocytes) metabolic routes which may be observed in human and 
diÔ¨Äerent animal species. IdentiÔ¨Åcation of metabolic products (metabolic 
identities or MetIDs) via in vitro systems plays a crucial role in validating 
the use of animal species for screening and synthesis planning, in or- 
der to protect metabolic hotspots that are directly relevant to man. On 
occasions, the samples prepared for intrinsic clearance measurements 
are submitted to the qualitative liquid chromatography-mass spectrom- 
etry (LC-MS) evaluation. For the analysis, both ultraviolet (UV) chro- 
matograms and mass spectra are acquired. The UV chromatograms are 
applied to quantify each peak given as the percentage (%) of the run. 
Subsequently, the peaks representing > 5% of the UV chromatogram are 
obtained by mass spectra, followed by the identiÔ¨Åcation of tentative 
MetIDs. Herein, we aimed to correlate interpretations obtained by CNN 
and GCNN frameworks to the metabolic transformations proposed by 
the experiments. 
3 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 1. IdentiÔ¨Åcation of molecules for interpretability assessment. A summary 
of the analysis is presented, as described in the text. 
Results and discussion 
Data for interpretability assessment 
We have systematically searched the test set for publicly available 
compounds for which internally derived MetIDs were identiÔ¨Åed. A sum- 
mary is shown in Fig. 1 . As described above, both CNN and GCNN mod- 
els were cross-validated and optimized using 80% of the available data 
(training set), whereas the remaining 20% (28,025 molecules) were 
used for model validation (test set) and model interpretability anal- 
ysis. In addition, test set predictions were evaluated against the av- 
eraged pixel intensities for corresponding interpretations, as to eval- 
uate the interpretation method sensitivity to the actual CNN predic- 
tions. Out of 28,025 molecules, 4354 (16%) had their chemical struc- 
ture publicly disclosed. From these, we selected 2394 compounds (55%) 
that were predicted within a two-fold error margin for both CNN and 
GCNN models in at least a single common clearance endpoint. Two- 
fold prediction error (0.30 logarithmic units) was chosen to reÔ¨Çect the 
experimental error of both hepatocyte and microsomal clearance as- 
say measurements [23] . Furthermore, we only examined compounds 
with internally available MetIDs for the corresponding clearance as- 
says. Following these criteria, only < 1% of the initial test set com- 
pounds (185 molecules) qualiÔ¨Åed for our analysis. From these, we se- 
lected several examples to discuss, one for each predicted clearance 
endpoint. 
Performance robustness of CNN and GCNN models 
To evaluate performance robustness on novel chemical series, we 
applied Bemis-Murcko (BM) scaÔ¨Äold deÔ¨Ånition to estimate the chemi- 
cal overlap between randomly deÔ¨Åned training and test sets [38] . We 
identiÔ¨Åed 64,393 unique BM scaÔ¨Äolds in our data, 6328 of which were 
shared between the training and the test set, which corresponded to 
54,292 and 17,757 compounds, respectively. Such high overlap was ex- 
pected given the stochastic nature of random splitting, which may as 
well limit the potential of machine learning models to conÔ¨Ådently pre- 
dict new chemistry. In that respect, we analyzed the model performance 
only on singleton compounds (10,268 molecules) that consituted the 
test set (i.e., molecules that had no other analogs according to BM scaf- 
fold deÔ¨Ånition). More challenging data splitting strategies for our mod- 
els were previously examined elsewhere [23] . Fig. S2 displays the CNN 
and GCNN model performance for each individual clearance endpoint as 
evaluated on all and only singleton test set molecules. Performance dif- 
ferences between all and only singleton compounds were insigniÔ¨Åcant 
(up to 0.03, depending on the endpoint), demonstrating that the models 
were capable of accurately predicting compounds that belonged to un- 
seen chemistry. Provided that none of the 185 molecules which qualiÔ¨Åed 
for the interpretability analysis were singletons, we could not demon- 
strate that the interpretations obtained through studied interpretability 
frameworks would correlate with their MetID experiments. However, 
given that the models were predictive for singleton molecules, it can- 
not be entirely excluded that derived interpretability models would cor- 
rectly interpret novel chemistry as well. 
In addition, we evaluated the prediction robustness relative to the 
uncertainty estimates for the compounds satisfying the above mentioned 
criteria. Uncertainty estimates for CNNs were obtained via rotational 
perturbations (diÔ¨Äerent orientations of the same molecule were used 
as inputs), whereas for GCNNs the uncertainties were retrieved using 
three models with diÔ¨Äerent seed values trained under the same con- 
ditions. Fig. S3 shows box plot distribution of standard deviations for 
CNN and GCNN predictions across diÔ¨Äerent clearance endpoints. We 
noted relatively consistent uncertainty distributions for the discussed 
clearance measurements when focusing on individual modeling frame- 
works. Prediction uncertainties were slightly higher for GCNN models, 
with a wider distribution of standard deviations compared to the equiv- 
alent CNN models. Median values for both CNN and GCNN distributions 
were low, demonstrating that individual predictions were generally ro- 
bust. Further investigation of diÔ¨Äerent calibration approaches using ex- 
perimental error estimates would likely be required, which is an ongoing 
area of interest for practical applications. 
Sensitivity of CNN interpretation methods 
We conducted a global sensitivity analysis of the CNN interpreta- 
tion methods to the corresponding prediction values. For this purpose, 
normalized mean pixel intensities for each interpreted compound were 
correlated with model predictions obtained for each endpoint. Fig. 2 
demonstrates a strong correlation across diÔ¨Äerent clearance endpoints 
and interpretation methods, conÔ¨Årming that the regions higlighted by 
interperetation methods are sensitive to the order of magitude of pre- 
dicted values. This correlation is slightly stronger in CAMs, thus mak- 
ing this method more sensitive. Curiously, CAMs show strong negative 
correlation (as opposed to IGs) across all endpoints, which could be at- 
tributed to the latent space used to build CAMs. It is thus plausible that 
during the CNN training the CLint values are mapped to the low la- 
tent space values, which in turn produces negative correlation in CAMs. 
Other potential reasons include the application of high degree inter- 
polation algorithms to resample latent CNN dimensions with respect 
to the original image dimensions, as well as the color map selection 
where low pixel intensities are assigned to high CLint values and vice 
versa. 
We furthermore investigated the sensitivity of CNN interpretation 
methods to diÔ¨Äerent molecular orientations. As our models were ini- 
tially built using diÔ¨Äerent augmentation techniques and were robust to 
a number of molecular image augmentations, we reasoned that inves- 
tigated CNN interpretation methods should show similar level of ro- 
bustness as the models supporting them. The ability of CNN interpreta- 
tions to show rotational invariability to diÔ¨Äerent molecular orientations 
would demonstrate their resilience to perturbation attacks in a practical 
setting (e.g., when a molecular structure is requested to be displayed in a 
particular pose). Other perturbation approaches such as image blurring, 
application of occlusion masks, or replacement of image patches would 
be less meaningful to consider given that the preparation of molecular 
images follows a set of predeÔ¨Åned rules (see Convolutional neural net- 
work models section), unlike in other image analysis applications where 
often raw and quality deprived images are considered. As shown in Figs. 
S4-S5 of the Supplementary material both the predicted clearance values 
and the structural features highlighted by the interpretations are con- 
sistent across diÔ¨Äerent rotations. Clearly, the conÔ¨Årmation of prediction 
reliability and interpretation consistency establishes a strong prerequi- 
site for the practical consideration of molecular image-based methods 
in medicinal chemistry, as demonstrated in the following section. 
4 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 2. Global sensitivity of CNN interpretation methods. Scatter plots show the correlation between the normalized mean pixel intensities and predicted CLint values 
(HH CLint, blue; HLM CLint, orange; RH CLint, red; DH CLint, green) for both CNN interpretation methods (CAMs, top; IGs, bottom). At the top right corner of each 
plot a Pearson‚Äôs r value quantiÔ¨Åes the correlation. 
Table 1 
Agreement between diÔ¨Äerent interpretability methods as indi- 
cated by Spearman correlation coeÔ¨Écients. 
Method pair 
HH CLint 
HLM CLint 
RH CLint 
DH CLint 
CAM ‚Äì IG 
0.10 
0.06 
0.05 
0.09 
CAM ‚Äì MCTS 
0.43 
0.56 
0.05 
0.40 
IG ‚Äì MCTS 
0.02 
0.04 
0.02 
0.01 
Agreement between interpretability methods 
For the compounds fulÔ¨Ålling our criteria, we investigated the agree- 
ment between the three interpretability methods (CAMs, IGs, and MCTS) 
by extracting the pixel values from their interpretation maps and cal- 
culating pairwise Spearman correlation coeÔ¨Écients. The greater the 
Spearman correlation coeÔ¨Écient, the greater the agreement between 
the methods, thus demonstrating their ability to highlight same sub- 
structural motifs. Provided that MCTS method was herein applied to 
molecular graphs, we built an equivalent image representation for MCTS 
outputs where highlighted portions of molecular structure were assigned 
pixel values of 1, whereas the remaining (i.e., no contribution accord- 
ing to MCTS) were kept at 0. Table 1 summarizes Spearman correlation 
coeÔ¨Écients obtained for the pairwise method comparisons, as assessed 
across all four clearance endpoints. Despite being applied on diÔ¨Äerent 
data formats and model architectures, CAMs and MCTS showed the 
highest correlation among all method pairs. The greatest disagreement 
was noted between IGs and MCTS. Endpoint-wise, RH CLint showed the 
greatest variability between the method pairs, scoring overall the lowest 
coeÔ¨Écient values. Altogether, Spearman correlation coeÔ¨Écients showed 
no meaningful association for the majority of methods and clearance 
endpoints, indicating that their interpretations could be at most com- 
plementary when applied together. 
Interpretation examples 
To simplify model interpretability analysis, each interpretation 
method was programed to yield an interpretation layer characterized 
with a pre-speciÔ¨Åed coloring scheme, that would be then subsequently 
superposed onto the predicted molecular image. For CAMs and IGs (CNN 
model), continuous color scales were applied to indicate increasing 
propensity for metabolic transformations: from dark blue to orange for 
CAMs, and from blue to red for IGs. For MCTS (GCNN model), only the 
most contributing molecular substructure for each compound was con- 
sidered and highlighted, which also posed a limitation for this method. 
Exemplary interpretations for diÔ¨Äerent compounds and clearance end- 
points are displayed in Figs. 3‚Äì6 . Both the experimental and predicted 
clearance values shown in the Ô¨Ågures are given in a logarithmic scale. 
As shown in Fig. 3 , compound A has a moderately high experimen- 
tal HH CLint of 1.25 and was accurately predicted by both the CNN and 
GCNN models, displaying only a marginal error diÔ¨Äerence of 0.06 and 
5 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 3. Interpretation of HH CLint pre- 
diction for compound A. Shown are CNN 
and GCNN model interpretations obtained 
for the predicted HH CLint endpoint for 
compound A. Interpretations are comple- 
mented with the full MetID scheme, as 
well as the experimental and the predicted 
endpoint values for each model. 
0.16, respectively. Experimentally obtained HH CLint MetID for com- 
pound A shows that 48% of the molecule remained unchanged (was 
not subjected to HH CLint metabolism), whereas 41% were metaboli- 
cally transformed to plausible products. The remaining 11% could not 
be chemically characterized by the LC-MS procedure. Major metabolites 
were derived through the successive transformation of oxidation and 
glucuronidation (22%), only desaturation (8%), only glucuronidation 
(6%), and a combination of both desaturation and glucuronidation (5%). 
Both N- (nitrogens of indazole and pyridine) and O-glucuronidation (hy- 
droxyl group of carboxylic acid) reactions were detected, whereas the 
sp 3 carbons found in the aliphatic chain were subjected to desatura- 
tion. Oxidation process was identiÔ¨Åed to take place on the pyridine 
ring. For the CNN model interpretations, functional groups undergo- 
ing glucuronidation show the lowest propensity for the metabolic trans- 
formation (both CAM and IGs) ( Fig. 3 ). On another hand, area around 
the aliphatic chain (adjacent to the benzene ring) is characterized with 
greater pixel intensity by both CAM and IG methods, although this trans- 
formation was experimentally quantiÔ¨Åed to contribute the least to the 
metabolic output. Oxidation of the pyridine ring is highlighted as having 
an average intensity by CAM and a slightly higher intensity by IGs. As for 
6 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 4. Interpretation of HLM CLint prediction for compound B. Shown are CNN and GCNN model interpretations obtained for the predicted HLM CLint endpoint 
for compound B. Interpretations are complemented with the full MetID scheme, as well as the experimental and the predicted endpoint values for each model. 
the GCNNs, MCTS algorithm highlights indazole ring as the most con- 
tributing substructure to the prediction which, according to the avail- 
able MetID, was conjugated via N-glucuronidation. Carboxylic acid al- 
cohol, suggested by MetID to undergo glucuronidation, has not been 
highlighted by the interpretability methods. However, LC-MS does not 
distinguish between the potential sites of transformation or whether O- 
or N-glucuronidation takes place. In this example, all three interpretabil- 
ity approaches were complementary to each other, with not a single 
method highlighting all experimentally detected metabolic transforma- 
tions. For HH CLint, this compound shared the same BM scaÔ¨Äold with 
another 16 compounds, 12 of which were in the training set. 
Fig. 4 displays compound B [39] which has a high experimental 
HLM Clint (HLM CLint exp = 2.03) and comparably predicted CNN (HLM 
CLint pred = 1.97) and GCNN (HLM CLint pred = 1.91) model values. For 
this compound, HLM CLint MetID shows that only 34% of the metabolic 
output is chemically characterized. This can further be disseminated into 
7 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 5. Interpretation of RH CLint prediction for 
compound C. Shown are CNN and GCNN model 
interpretations obtained for the predicted RH 
CLint endpoint for compound C. Interpretations 
are complemented with the full MetID scheme, as 
well as the experimental and the predicted end- 
point values for each model. 
the oxidation-mediated ring opening (26%), free radical peroxidation 
(4%), and oxidation (4%) mechanisms, all detected for the imidazopy- 
ridine ring. Indeed, oxidative opening of the imidazopyridine ring was 
predictable since structurally similar indoles undergo similar oxidative 
cleavage via the P450-mediated oxidation [40] . Both CAM and IGs cor- 
rectly highlight imidazopyridine moiety (the latter focusing on the imi- 
dazole portion) as a metabolic hotspot, which accounts for all three iden- 
tiÔ¨Åed metabolic products. In addition, IGs predict pyrazole and oxadia- 
zole as additional structural motifs undergoing metabolism. On another 
hand, MCTS (GCNN model) suggests that phenylpyrazole moiety is the 
major contributing feature to the compound B metabolism. However, 
it cannot be entirely excluded that among the metabolites unidentiÔ¨Åed 
by LC-MS occurs a byproduct (or several) generated via these substruc- 
tures. For HLM CLint, the BM scaÔ¨Äold of this compound was contained 
in another 29 compounds, 18 of which were part of the training set. 
In Fig. 5 , compound C shows a relatively low experimental RH CLint 
value (RH CLint exp = 0.99), which was slightly overpredicted by both 
CNN (RH CLint pred = 1.23) and GCNN (RH CLint pred = 1.29) models. 
Here, MetID clearly displays both N- and O-glucuronidation as the ma- 
jor quantiÔ¨Åable metabolites (12%) whereas the oxidation of multiple 
8 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Fig. 6. Interpretation of DH CLint prediction 
for compound D. Shown are CNN and GCNN 
model interpretations obtained for the pre- 
dicted DH CLint endpoint for compound D. 
Interpretations are complemented with the 
full MetID scheme, as well as the experimen- 
tal and the predicted endpoint values for each 
model. 
functional groups and aromatic rings was detected but not quantiÔ¨Åed 
by LC-MS. Additionally, the transformation coupling oxidation and glu- 
tathione conjugation was noted as well. CAM correctly highlights a large 
part of the tricyclic ring as the potential site of metabolism, which was 
conÔ¨Årmed by the MetID to undergo oxidation, glucuronidation, and glu- 
tathione conjugation. On another hand, IGs characterizes tricyclic ni- 
trogens with a low propensity for metabolic transformations, whereas 
the area around the tertiary amine of the tetrahydroisoquinoline ring 
is highlighted as a region of high metabolic propensity. In the latter, 
the activated C ùõº is a well-known metabolic soft spot for compound 
classes such as the displayed tetrahydroisoquinoline and other fused aryl 
piperidines. These are particularly vulnerable to oxidative metabolism 
(as indicated by the MetID), which may lead to the formation of highly 
reactive and toxic iminium ions [41] . In addition, CAM correctly high- 
lights the benzene ring (oxidation according to the MetID), that is only 
in part detected by IGs. For CAM interpretation, an average pixel inten- 
sity is shown for the isobutyl group and the sp 2 carbons of the Michael 
acceptor, all undergoing oxidation. The oxidation of the sp 2 carbons was 
9 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
also conÔ¨Årmed by IGs. Interestingly, unlike in Fig. 3 , hydroxyl group of 
the carboxylic acid which participates in the glucuronide conjugation is 
correctly highlighted by IGs, whereas in CAM it is shown to have only a 
minor propensity for metabolic transformation. MCTS algorithm high- 
lights only 4-methylstyrene as the most contributing molecular substruc- 
ture to the GCNN prediction, which was suggested by MetID to undergo 
oxidative metabolism. The majority of metabolic transformations were 
detected by CAM, which was complemented only to a minor extent by 
IGs. For RH CLint, this compound shared its BM scaÔ¨Äold with another 
451 compounds, 359 of which were present in the training set. 
Fig. 6 discusses compound D which has a low DH CLint of 0.78 and 
accurately predicted values by both CNN (DH CLint pred = 0.73) and 
GCNN (DH CLint pred = 0.88). A major portion of the available par- 
ent compound remained relatively unchanged (77%). Main metabolic 
transformations are reported for the pyrazole ring (oxidation, 14%) and 
ether functional group (demethylation, 4%), the latter being addition- 
ally transformed by oxidation to a carboxylic acid moiety (3%). Each 
of the remaining reported metabolic reactions accounted for < 1% of 
presence (methylation, oxidation, N-demethylation, N-oxide formation, 
and oxidation/glucuronidation). The highest pixel intensity in CAM is 
reported for the ether group, which undergoes O-demethylation, oxi- 
dation, and glucuronidation. This is only insigniÔ¨Åcantly highlighted by 
IGs. However, IGs correctly interpret pyrazole ring as the key metabolic 
hotspot (oxidation and N-demethylation), which is by CAM highlighted 
with only an average intensity. In MCTS, a structurally extended pyra- 
zole pattern is highlighted as the most contributing molecular feature, in 
accordance with the major reported metabolite. N-methylation of pyri- 
dine, quinoline, and amide nitrogen are not captured by either CAM 
or IGs. Similar observations are made for aryl oxidation and N-oxide 
formation. Here, IGs and MCTS correctly predict the location of the 
main metabolic transformation, whereas CAM complement interpreta- 
tion Ô¨Åndings with the detected modiÔ¨Åcations on the ether. In addition 
to DH CLint MetID, compound D was also characterized with MetIDs 
for HH CLint and RH CLint experiments, which are provided in the Sup- 
plementary material (Figs. S6-S7). In short, similar metabolic transfor- 
mations (yet in diÔ¨Äerent ratios) were present for both HH CLint (Fig. 
S6) and RH CLint (Fig. S7), with 86% of the parent compound D pre- 
served in HH CLint and 47% in RH CLint. However, we noticed that the 
same CNN interpretation methods highlighted diÔ¨Äerent substructural 
features for all three MetID-containing clearance endpoints ( Figs. 6 , S6- 
S7). For HH CLint (Fig. S6), CAM method assigns the greatest pixel in- 
tensity to the quinoline ring, although it accounted only for 1% of the 
detected compounds. No clear substructural features were prioritized 
for IGs. On the other hand, MCTS correctly recognizes pyrazole as the 
major metabolic hotspot (oxidation and methylation). Interestingly, for 
RH CLint (Fig. S7) all three methods correctly predict pyrazole ring as 
the major substructural motif undergoing RH metabolism, orchestrated 
via numerous transformative mechanisms. Besides this compound, we 
detected another two molecules with DH CLint measurements sharing 
the same BM scaÔ¨Äold, both present in the training set. 
Conclusions 
Herein, we have explored several model interpretability frameworks 
which build upon the existing multi-task CNN and GCNN models that 
learn from in-house intrinsic clearance data. For this purpose, we ap- 
plied CAMs and IGs to interpret CNN predictions and a built-in MCTS 
algorithm to explain Chemprop GCNN outputs. For an adequate inter- 
pretability assessment, only publicly disclosed compounds that were 
accurately predicted by both CNN and GCNN models and were inter- 
nally reported with chemically characterized MetIDs were considered 
for the analysis. This permitted us to draw relatively clear conclusions 
on the applicability of CNN- and GCNN-based interpretations to explain 
metabolism-related chemical modiÔ¨Åcations obtained through the exper- 
imental design. Despite being partially trained and tested on the com- 
mon substructures, the models proved to be robust on unseen chemistry. 
Only a slight increase in RMSE values was detected when compared to 
all test set predictions. 
Provided that MetID experiments are only rarely performed (largely 
for few project candidates) and that only a handful of examples could 
be eÔ¨Éciently interpreted, large scale interpretability assessment which 
considers in-house-generated MetIDs would oÔ¨Äer only a limited insight 
into the general interpretation capabilities of such models. For a more 
comprehensive analysis, a more frequent generation of MetID experi- 
ments (often limited by costs), or a collaborative resource framework 
bringing together large pharmaceutical companies, would be required. 
However, we have still demonstrated that mean pixel intensities as- 
sociated with interpretation layers were highly correlated with CNN 
predictions. In addition, there was only a little overlap between sub- 
structures highlighted by diÔ¨Äerent methods, suggesting that these inter- 
pretability frameworks could potentially generate complementary infor- 
mation for the metabolic hotspot assessment. Furthermore, these meth- 
ods displayed strong interpretation robustness to diÔ¨Äerent orientations 
of molecular images, supported by consistently highlighted substruc- 
tural features in these images. On a case-by-case basis, no clear pref- 
erence could be given to any of the evaluated interpretability meth- 
ods, as it was frequently observed that both CNN and GCNN interpre- 
tations were complementary to each other. Interestingly, CAM and IG 
algorithms often provided diÔ¨Äerent interpretations, which could be at- 
tributed to their global- and local-enabled foci, respectively. In addi- 
tion, model interpretations frequently highlighted structural features 
that were not identiÔ¨Åed by MetIDs. However, provided that LC-MS out- 
puts are often not chemically characterized in their entirety, it cannot 
be altogether excluded that a part of the unidentiÔ¨Åed metabolic out- 
put contains products that result from model-associated substructural 
motifs. For these reasons, the application of these methods could be en- 
visioned in concert to guide medicinal chemists‚Äô intuition towards or 
away from plausible metabolic transformations. For example, once the 
predicted clearance values are obtained, a(n) (experienced) medicinal 
chemist may begin to build conÔ¨Ådence in a particular interpretability 
method which, according to the chemist‚Äôs experience, provides plausi- 
ble explanations for an investigated drug chemotype. This would also 
prompt the application to other highlighted areas of chemical structure 
that are less straightforward to deconvolute but may lead, for instance, 
to rarely observed metabolic transformation associated with safety li- 
abilities. Such suspicions may later be reconciled by an extensive lit- 
erature search. In cases where less knowledge about particular chemi- 
cal series exists, conjoined application of two or more interpretability 
frameworks, either through weighted scoring (where overlapping fea- 
tures would receive higher scores) or a simple combination of high- 
lighted substructures would be recommended. Provided that metabolic 
modiÔ¨Åcations could simultaneously take place at diÔ¨Äerent, often dis- 
connected substructural motifs, and that some interpretability modules 
frequently highlight only a single structural locus, combined use of 
diÔ¨Äerent interpretation methods would secure better coverage of po- 
tential transformation sites. These are just some of the potential ap- 
plication scenarios which merit our further investigation and interest. 
That being said, potential future directions extending this work include, 
but are not limited to: a) improvement of model performance with re- 
spect to experimental error of measurement, b) further exploration of 
interpretability methods and the development of custom-made algo- 
rithms that focus on molecular image representations, c) detailed guid- 
ance on use and best practices, including when and how to apply in- 
terpretation methods alone or in combination, and d) continuous ap- 
plication and prospective validation on ongoing medicinal chemistry 
projects. 
Declaration of Competing Interest 
The authors declare that they have no known competing Ô¨Ånancial 
interests or personal relationships that could have appeared to inÔ¨Çuence 
the work reported in this paper. 
10 
A. Mart√≠nez Mora, M. Mogemark, V. Subramanian et al. 
ArtiÔ¨Åcial Intelligence in the Life Sciences 2 (2022) 100048 
Supplementary materials 
Supplementary material associated with this article can be found, in 
the online version, at doi: 10.1016/j.ailsci.2022.100048 . 
References 
[1] Lavecchia A. Machine-learning approaches in drug discovery: methods and applica- 
tions. Drug Discov. Today 2015;20:318‚Äì41 . 
[2] Lo Y, Rensi SE, Torng W, Altman RB. Machine learning in chemoinformatics and 
drug discovery. Drug Discov. Today 2018;23:1538‚Äì46 . 
[3] Miljkovi ƒá F, Rodr√≠guez-P√©rez R, Bajorath J. Impact of artiÔ¨Åcial intelligence on com- 
pound discovery, design, and synthesis. ACS Omega 2021;6:33293‚Äì9 . 
[4] Rodr√≠guez-P√©rez R, Miljkovi ƒá F, Bajorath J. Machine learning in chemoinformatics 
and medicinal chemistry. Annu. Rev. Biomed. Data Sci. 2022;5:43‚Äì65 . 
[5] Rodr√≠guez-P√©rez R, Bajorath J. Multitask machine learning for classifying highly and 
weakly potent kinase inhibitors. ACS Omega 2019;4:4367‚Äì75 . 
[6] Obrezanova O, Martinsson A, Whitehead T, Mahmoud S, Bender A, Miljkovi ƒá F, 
Grabowski P, Irwin B, Oprisiu I, Conduit G, Segall M, Smith GF, Williamson B, Wini- 
warter S, Greene N. Prediction of in vivo pharmacokinetic parameters and time‚Äì
exposure curves in rats using machine learning from the chemical structure. Mol. 
Pharm. 2022;19:1488‚Äì504 . 
[7] Miljkovi ƒá F, Martinsson A, Obrezanova O, Williamson B, Johnson M, Sykes A, Ben- 
der A, Greene N. Machine learning models for human in vivo pharmacokinetic pa- 
rameters with in-house validation. Mol. Pharm. 2021;18:4520‚Äì30 . 
[8] Mayr A, Klambauer G, Unterthiner T, Hochreiter S. DeepTox: toxicity prediction 
using deep learning. Front. Environ. Sci. 2016;3:e80 . 
[9] David L, Thakkar A, Mercado R, Engkvist O. Molecular representations in AI-driven 
drug discovery: a review and practical guide. J. Cheminform. 2020;12:e56 . 
[10] Hansen K, Baehrens D, Schroeter T, Rupp M, M√ºller K-R. Visual interpretation of 
kernel-based prediction models. Mol. Inform. 2011;30:817‚Äì26 . 
[11] Balfer J, Bajorath J. Introduction of a methodology for visualization and 
graphical interpretation of Bayesian classiÔ¨Åcation models. J. Chem. Inf. Model. 
2014;54:2451‚Äì68 . 
[12] Balfer J, Bajorath J. Visualization and interpretation of support vector machine ac- 
tivity predictions. J. Chem. Inf. Model. 2015;55:1136‚Äì47 . 
[13] Polishchuk P. Interpretation of quantitative-structure activity relationship models: 
past, present, and future. J. Chem. Inf. Model. 2017;57:2618‚Äì39 . 
[14] Rodr√≠guez-P√©rez R, Bajorath J. Interpretation of compound activity predictions from 
complex machine learning models using local approximations and Shapley values. 
J. Med. Chem. 2020;63:8761‚Äì77 . 
[15] Rodr√≠guez-P√©rez R, Bajorath J. Interpretation of machine learning models using 
Shapley values: application to compound potency and multi-target activity predic- 
tions. J. Comput.-Aided Mol. Des. 2020;34:1013‚Äì26 . 
[16] Rodr√≠guez-P√©rez R, Bajorath J. Explainable machine learning for property predic- 
tions in compound optimization. J. Med. Chem. 2021;64:17744‚Äì52 . 
[17] Shen D, Wu G, Suk H-I. Deep learning in medical image analysis. Ann. Rev. Biomed. 
Eng. 2017;19:221‚Äì48 . 
[18] Moen E, Bannon D, Kudo T, Graf W, Covert M, Van Halen D. Deep learning for 
cellular image analysis. Nature Meth 2019;16:1233‚Äì46 . 
[19] Fernandez M, Ban F, Woo G, Hsing M, Yamazaki T, LeBlanc E, Rennie PS, Welch WJ, 
Cherkasov A. Toxic Colors: the use of deep learning for predicting toxicity of com- 
pounds merely from their graphic images. J. Chem. Inf. Model. 2018;58:1533‚Äì43 . 
[20] Cort√©s-Ciriano I, Bender A. KekuleScope: prediction of cancer cell line sensitivity 
and compound potency using convolutional neural networks trained on compound 
images. J. Cheminform. 2019;11:e41 . 
[21] Iqbal J, Vogt M, Bajorath J. Prediction of activity cliÔ¨Äs on the basis of images using 
convolutional neural networks. J. Comput.-Aided Mol. Des. 2021;35:1157‚Äì64 . 
[22] Yoshimori A. Prediction of molecular properties using molecular topographic map. 
Molecules 2021;26:e4475 . 
[23] Mart√≠nez Mora A, Subramanian V, Miljkovi ƒá F. Multi-task convolutional neural net- 
works for predicting in vitro clearance endpoints from molecular images. J. Com- 
put.-Aided Mol. Des. 2022;36:443‚Äì57 . 
[24] Salahuddin Z, WoodruÔ¨Ä HC, Chatterjee A, Lambin P. Transparency of deep neural 
networks for medical image analysis: a review of interpretability methods. Comput. 
Biol. Med. 2022;140:e105111 . 
[25] Zhong S, Hu J, Yu X, Zhang H. Molecular image-convolutional neural network 
(CNN) assisted QSAR models for predicting contaminant reactivity toward OH rad- 
icals: transfer learning, data augmentation and model interpretation. Chem. Eng. J. 
2021;408:e127998 . 
[26] Iqbal J, Vogt M, Bajorath J. Learning functional group chemistry from molecu- 
lar images leads to accurate prediction of activity cliÔ¨Äs. Artif. Intell. Life. Sci. 
2021;1:e100004 . 
[27] K. He, X. Zhang, S. Ren, J. Sun, Deep residual learning for image recognition, arXiv 
(2015). https://doi.org/10.48550/arXiv.1512.03385. 
[28] Huber PJ. Robust estimation of a location parameter. Ann. Math. Statist. 
1964;35:73‚Äì101 . 
[29] Yang K, Swanson K, Jin W, Coley C, Eiden P, Gao H, Guzman-Perez A, Hopper T, 
Kelley B, Mathea M, Palmer A, Settels V, Jaakkola T, Jensen K, Barzilay R. Analyz- 
ing learned molecular representations for property prediction. J. Chem. Inf. Model. 
2019;59:3370‚Äì88 . 
[30] Zhou B, Khosla A, Lapedriza A, Oliva A, Torralba A. Learning deep features for 
discriminative localization. In: Proc. IEEE conference on computer vision and pattern 
recognition; 2016. p. 2921‚Äì9. doi: 10.1109/CVPR.2016.319 . 
[31] A. Paszke, S. Gross, F. Massa, A. Lerer, J. Bradbury, G. Chanan, T. Killeen, Z. Lin, 
N. Gimelshein, L. Antiga, A. Desmaison, A.K. Xamla, E. Yang, Z. Devito, M. Raison 
Nabla, A. Tejani, S. Chilamkurthy, Q. Ai, B. Steiner, L. Fang, J. Bai, S. Chintala, 
PyTorch: an imperative style, high-performance deep learning library, arXiv (2019). 
https://doi.org/10.48550/arXiv.1912.01703. 
[32] Shapley LS. A value for n-person games. In: Kuhn H, Tucker A, editors. Contributions 
to the theory of games ii. Princeton: Princeton University Press; 1953. p. 307‚Äì17 . 
[33] S. Lundberg, S.-.I. Lee, A uniÔ¨Åed approach to interpreting model predictions, arXiv 
(2017). https://doi.org/10.48550/arXiv.1705.07874. 
[34] N. Kokhlikyan, V. Miglani, M. Martin, E. Wang, B. Alsallakh, J. Reynolds, A. 
Melnikov, N. Kliushkina, C. Araya, S. Yan, O. Reblitz-Richardson. Captum: a 
uniÔ¨Åed and generic model interpretability library for PyTorch, arXiv (2020). 
https://doi.org/10.48550/arXiv.2009.07896. 
[35] M. Sundararajan, A. Taly, Q. Yan, Axiomatic attribution for deep networks, arXiv 
(2017). https://doi.org/10.48550/arXiv.1703.01365. 
[36] M.D. Zeiler, R. Fergus, Visualizing and understanding convolutional networks, arXiv 
(2013). https://doi.org/10.48550/arXiv.1311.2901. 
[37] H. Yuan, H. Yu, J. Wang, K. Li, S. Ji, On explainability of graph neural networks via 
subgraph explorations, arXiv (2021). https://doi.org/10.48550/arXiv.2102.05152. 
[38] Bemis GW, Murcko MA. The properties of known drugs. 1. Molecular frameworks. 
J. Med. Chem. 1996;39:2887‚Äì93 . 
[39] McCoull W, Boyd S, Brown MR, Coen M, Collingwood O, Davies NL, Doherty A, 
Fairley G, Goldberg K, Hardaker E, He G, Hennessy EJ, Hopcroft P, Hodgson G, 
Jackson A, Jiang X, Karmokar A, Lain√© A-L, Lindsay N, Mao Y, Markandu R, Mc- 
Murray L, McLean N, Mooney L, Musgrove H, Nissink JMW, PÔ¨Çug A, Pilla Reddy V, 
Rawlins PB, Rivers E, Schimpl M, Smith GF, Tentarelli S, Travers J, Troup RI, Wal- 
ton J, Wang C, Wilkinson S, Williamson B, Winter-Holt J, Yang D, Zheng Y, Zhu Q, 
Smith PD. Optimization of an imidazo[1,2- a ]pyridine series to aÔ¨Äord highly selec- 
tive type I1/2 dual Mer/Axl kinase inhibitors with in vivo eÔ¨Écacy. J. Med. Chem. 
2021;64:13524‚Äì39 . 
[40] Dalvie DK, Kalgutkar AS, Khojasteh-Bakht C, Obach RS, O‚ÄôDonnell JP. Biotransfor- 
mation reactions of Ô¨Åve-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 
2002;15:269‚Äì99 . 
[41] Kalgutkar AS, Gardner I, Obach RS, ShaÔ¨Äer CL, Callegari E, Henne KR, Mutlib AE, 
Dalvie DK, Lee JS, Nakai Y, O‚ÄôDonnell JP, Boer J, Harriman SP. A comprehensive 
listing of bioactivation pathways of organic functional groups. Curr. Drug. Metab. 
2005;6:161‚Äì225 . 
11 
